Readman Megan Rose, Oluseye Ayomide, Brighton Lisa Jane, Polden Megan, Fairman Ian, Parkinson Ian, Parkinson Caroline, Giebel Clarissa
Department of Primary Care and Mental Health, The University of Liverpool, Liverpool, UK.
NIHR Applied Research Collaboration North West Coast, Liverpool, UK.
BMC Public Health. 2025 Aug 22;25(1):2879. doi: 10.1186/s12889-025-24121-0.
In England, people aged > 60 are typically required to pay for their prescriptions. Whilst exemption criteria enable people living with specified long-term health conditions to receive free prescriptions, Parkinson's disease is omitted from this list. People with Parkinson's are often reliant upon medications, and evidence suggests that medical fees can reduce quality of life and medicine adherence. We, therefore, aimed to explore the impact of prescription charges on people with Parkinson's and their family care partners (caregivers).
This is a qualitative focus group study with people with Parkinson's and caregivers. Focus groups were semi-structured and conducted online. Participants were recruited through opportunity sampling. Eligible participants were adults aged 18 and over living in England who either (1) had a diagnosis of Idiopathic Parkinson's Disease or (2) provided unpaid care for someone with Parkinson's, including parents, adult children, siblings, or close friends. Data was analysed using reflexive thematic analysis within a critical realist paradigm.
Five focus groups were conducted with people with Parkinson's (n = 12) and caregivers (n = 12). All focus groups comprised both people with Parkinson's and caregivers. Thematic analysis identified three overarching themes: (1) The financial toll of medication and its ripple effects; (2) Lack of inclusion and support; and (3) Difficulties of seeking support. People affected by Parkinson's disagreed with current policy and suggestions of per-prescription charge re-evaluation were expressed.
Prescription charges have multifaceted negative impacts on people affected by Parkinson's. Current prescription charge policies, including their exemption criteria, should be reviewed, alongside initiatives to raise awareness of existing financial support systems, such as pre-payment certificates.
Study protocol and analysis strategy are pre-registered on Open Science Framework ( https://osf.io/y8ve5/ ).
在英国,60岁以上的人通常需要自行支付处方费用。虽然豁免标准使患有特定长期健康状况的人能够获得免费处方,但帕金森病被排除在该名单之外。帕金森病患者通常依赖药物治疗,有证据表明医疗费用会降低生活质量和药物依从性。因此,我们旨在探讨处方收费对帕金森病患者及其家庭护理伙伴(照顾者)的影响。
这是一项针对帕金森病患者及其照顾者的定性焦点小组研究。焦点小组采用半结构化形式,通过在线方式进行。参与者通过机会抽样招募。符合条件的参与者为居住在英国的18岁及以上成年人,他们要么(1)被诊断患有特发性帕金森病,要么(2)为帕金森病患者提供无偿护理,包括父母、成年子女、兄弟姐妹或亲密朋友。数据在批判实在论范式内采用反思性主题分析进行分析。
对帕金森病患者(n = 12)和照顾者(n = 12)进行了五个焦点小组访谈。所有焦点小组都包括帕金森病患者和照顾者。主题分析确定了三个总体主题:(1)药物治疗的经济负担及其连锁反应;(2)缺乏纳入和支持;(3)寻求支持的困难。受帕金森病影响的人不同意现行政策,并表达了重新评估每张处方收费的建议。
处方收费对受帕金森病影响的人有多方面的负面影响。应审查现行处方收费政策,包括其豁免标准,同时开展提高对现有财政支持系统(如预付费证书)认识的举措。
研究方案和分析策略已在开放科学框架(https://osf.io/y8ve5/)上预先注册。